BioCardia, Inc. SEC filings BCDA
BioCardia, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to Sep 27, 2007. Its latest annual report, Form 10-K, was filed on Mar 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Mar 24, 2026 | — |
| S-8 | Employee stock plan registration | Dec 18, 2025 | — |
| 424B5 | Prospectus supplement | Oct 24, 2025 | — |
| 424B4 | Prospectus | Sep 19, 2025 | — |
| S-1/A | Amended registration statement | Sep 17, 2025 | — |
| S-1 | Registration statement | Sep 16, 2025 | — |
| S-3 | Shelf registration | Jul 9, 2025 | — |
| 424B5 | Prospectus supplement | Jul 8, 2025 | — |
| S-3 | Shelf registration | Apr 30, 2025 | — |
| 424B5 | Prospectus supplement | Apr 4, 2025 | — |
| S-8 | Employee stock plan registration | Mar 26, 2025 | — |
| 424B5 | Prospectus supplement | Dec 2, 2024 | — |
| 424B4 | Prospectus | Aug 30, 2024 | — |
| 424B4 | Prospectus | Aug 30, 2024 | — |
| S-1MEF | Form s-1mef | Aug 29, 2024 | — |
| S-1/A | Amended registration statement | Aug 29, 2024 | — |
| S-1 | Registration statement | Aug 9, 2024 | — |
| S-8 | Employee stock plan registration | Mar 27, 2024 | — |
| S-3 | Shelf registration | Feb 14, 2024 | — |
| 424B5 | Prospectus supplement | Dec 6, 2023 | — |
| 424B5 | Prospectus supplement | Nov 17, 2023 | — |
| S-3 | Shelf registration | Oct 19, 2023 | — |
| 424B5 | Prospectus supplement | Jun 22, 2023 | — |
| S-8 | Employee stock plan registration | Mar 30, 2023 | — |
| S-3 | Shelf registration | Dec 19, 2022 | — |
| 424B5 | Prospectus supplement | Apr 12, 2022 | — |
| S-8 | Employee stock plan registration | Mar 30, 2022 | — |
| S-8 | Employee stock plan registration | Mar 30, 2021 | — |
| 424B5 | Prospectus supplement | Mar 30, 2021 | — |
| 424B5 | Prospectus supplement | Dec 16, 2020 | — |
| 424B5 | Prospectus supplement | Dec 15, 2020 | — |
| S-3 | Shelf registration | Oct 9, 2020 | — |
| 424B4 | Prospectus | Jun 18, 2020 | — |
| S-1/A | Amended registration statement | Jun 15, 2020 | — |
| FWP | Free writing prospectus | Jun 8, 2020 | — |
| S-1/A | Amended registration statement | May 26, 2020 | — |
| POS AM | Form pos am | Apr 20, 2020 | — |
| S-8 | Employee stock plan registration | Feb 13, 2020 | — |
| S-1 | Registration statement | Feb 13, 2020 | — |
| 424B4 | Prospectus | Aug 5, 2019 | — |
| S-1/A | Amended registration statement | Aug 1, 2019 | — |
| S-1/A | Amended registration statement | Jul 23, 2019 | — |
| S-1/A | Amended registration statement | Jul 15, 2019 | — |
| S-1/A | Amended registration statement | Jul 5, 2019 | — |
| S-1 | Registration statement | Apr 9, 2019 | — |
| S-8 | Employee stock plan registration | Apr 20, 2018 | — |
| S-3/A | Form s-3/a | Aug 25, 2017 | — |
| S-3/A | Form s-3/a | Jul 20, 2017 | — |
| S-3/A | Form s-3/a | Jun 28, 2017 | — |
| S-3 | Shelf registration | May 19, 2017 | — |
| S-8 | Employee stock plan registration | Feb 8, 2017 | — |
| 424B3 | Prospectus | Apr 28, 2010 | — |
| POS AM | Filing | Apr 22, 2010 | — |
| S-3 | Shelf registration | Feb 8, 2010 | — |
| 424B3 | Prospectus | Jan 11, 2010 | — |
| S-1 | Registration statement | Dec 18, 2009 | — |
Showing 56 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- BCDA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Sunnyvale, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 925741
- Former names
- Tiger X Medical, Inc. (until Oct 17, 2016); Cardo Medical, Inc. (until May 25, 2011); CLICKNSETTLE COM INC (until Oct 20, 2008); NAM CORP (until Mar 29, 2000)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.